Back
26 November 2025
The ITA, on behalf of the IWF, confirms that the Iraqi weightlifter Qasim Hasan Abdulhussein Al-Lami has agreed¹ to the consequences imposed for his anti-doping rule violation (ADRV).
The athlete tested positive for stanozolol metabolites after providing a sample on 30 October 2024 during an out-of-competition doping control conducted by the ITA under the testing and results management authority of the IWF.
Stanozolol is listed under the WADA Prohibited List as S1.1 Anabolic Androgenic Steroids (AAS). It is classified as a non-specified substance and prohibited at all times (in- and out-of-competition). Stanozolol is a synthetic anabolic steroid that promotes lean muscle growth and enhances strength.
When notified of the case, the athlete was provisionally suspended with immediate effect as from 9 December 2024.²
The athlete was previously sanctioned by the West Asia Regional Anti-Doping Organisation (WARADO) Doping Hearing Panel with a period of ineligibility of four years from 12 November 2017 until 11 November 2021 for the presence of the prohibited substances furosemide and testosterone in a sample collected on 13 April 2017. Therefore, the violation of 30 October 2024 was the athlete’s second ADRV. As a result, the applicable period of Ineligibility was up to 8 years.
The athlete did not challenge his ADRV and agreed with the consequences for his ADRV under the IWF ADR as proposed by the ITA. Accordingly, the case was resolved via an acceptance of consequences.
Due to his early admission of the ADRV, the athlete was entitled to a one-year reduction of the applicable period of ineligibility as set forth in article 10.8.1 of the IWF ADR.³
The seven-year period of ineligibility is from 9 December 2024 until 8 December 2031. Additionally, all the athlete’s individual competitive results from the date of the sample collection (30 October 2024) to the start of the provisional suspension (9 December 2024) are disqualified, including forfeiture of medals, points and prizes.
The decision may be challenged before the appeals division of the Court of Arbitration for Sport by the parties with a right of appeal in accordance with Article 13.2.3 of the IWF anti-doping rules.
The ITA will not comment further on this case.
¹ Athletes have the right to choose not to have their case referred to a hearing panel. In these instances, the anti-doping organisation will assess the athlete’s case file and establish the applicable consequences pursuant to the anti-doping rules and the athlete will have the right to accept the proposed consequences. If the athlete refuses the proposed consequences, the case is transferred to a hearing panel. This resolution mechanism is provided for in articles 8.3.1 and 8.3.3 of the IWF anti-doping rules and 8.3 of the World Anti-Doping Code and is commonly referred to as an agreement on consequences and is deemed an IWF/ITA decision. The athlete’s National Anti-Doping Organisation and the World Anti-Doping Agency have the right to appeal the agreement on consequences before the competent appeal body.
² Details of the Athlete’s provisional suspension were published by the ITA https://ita.sport/sanction/international-weightlifting-federation-iwf/
³ Article 10.8.1 of the IWF ADR (and World Anti-Doping Code) provides for a one-year reduction for certain ADRVs based on early admission and acceptance of sanction. This applies where an athlete after being notified by IWF /ITA of a potential ADRV that carries an asserted period of Ineligibility of four (4) or more years, admits the violation and accepts the asserted period of Ineligibility no later than twenty (20) days after receiving notice of an ADRV charge. Where the athlete receives the one-year reduction under Article 10.8.1, no further reduction in the period of Ineligibility is allowed.
